A new combination strategy to enhance apoptosis in cancer cells by using nanoparticles as biocompatible drug delivery carriers

Some experimental and clinical studies have been conducted for the usage of chemotherapeutic drugs encapsulated into nanoparticles (NPs). However, no study has been conducted so far on the co-encapsulation of doxorubicin (Dox) and epoxomicin (Epo) into NPs as biocompatible drug delivery carriers. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kucuksayan, Ertan, Bozkurt, Fatih, Yilmaz, Mustafa Tahsin, Sircan-Kucuksayan, Aslinur, Hanikoglu, Aysegul, Ozben, Tomris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219778/
https://www.ncbi.nlm.nih.gov/pubmed/34158544
http://dx.doi.org/10.1038/s41598-021-92447-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219778/
https://www.ncbi.nlm.nih.gov/pubmed/34158544
http://dx.doi.org/10.1038/s41598-021-92447-x

Ejemplares similares